BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21876507)

  • 1. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.
    Szczepankiewicz A; Rybakowski JK; Suwalska A; Hauser J
    Neuro Endocrinol Lett; 2011; 32(4):545-51. PubMed ID: 21876507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
    Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder.
    Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Kunugi H; Koyama T
    Psychiatr Genet; 2006 Apr; 16(2):49-50. PubMed ID: 16538178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.
    Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Rajewska-Rager A; Dmitrzak-Weglarz M; Wilkosc M; Skibinska M; Hauser J
    J Affect Disord; 2011 Nov; 134(1-3):138-44. PubMed ID: 21764460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
    Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Szczepankiewicz A; Hauser J
    Pharmacogenomics; 2008 Nov; 9(11):1595-603. PubMed ID: 19018715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes involved in stress response influence lithium efficacy in bipolar patients.
    Szczepankiewicz A; Narozna B; Rybakowski JK; Kliwicki S; Czerski P; Dmitrzak-Węglarz M; Skibińska M; Twarowska-Hauser J; Pawlak J
    Bipolar Disord; 2018 Dec; 20(8):753-760. PubMed ID: 29578315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder.
    Rybakowski JK; Dmitrzak-Weglarz M; Suwalska A; Leszczynska-Rodziewicz A; Hauser J
    Pharmacopsychiatry; 2009 Jan; 42(1):20-2. PubMed ID: 19153942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between the PREP gene and lithium responsive bipolar disorder.
    Mamdani F; Sequeira A; Alda M; Grof P; Rouleau G; Turecki G
    BMC Psychiatry; 2007 Feb; 7():9. PubMed ID: 17324276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
    World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.
    Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Słopień A; Czerski PM; Leszczyńska-Rodziewicz A; Hauser J
    Pharmacol Rep; 2005; 57(6):761-5. PubMed ID: 16382194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
    Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Takeda M; Kunugi H; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):204-8. PubMed ID: 17822820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of circadian clock genes and prophylactic lithium response.
    Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
    Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.
    Washizuka S; Ikeda A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):421-4. PubMed ID: 14604458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the involvement of the glucocorticoid receptor gene in bipolar disorder in an isolated northern Swedish population.
    Ceulemans S; De Zutter S; Heyrman L; Norrback KF; Nordin A; Nilsson LG; Adolfsson R; Del-Favero J; Claes S
    Bipolar Disord; 2011; 13(7-8):614-23. PubMed ID: 22085474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
    Rybakowski JK; Skibinska M; Suwalska A; Leszczynska-Rodziewicz A; Kaczmarek L; Hauser J
    Hum Psychopharmacol; 2011 Mar; 26(2):168-71. PubMed ID: 21437990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FKBP5 polymorphism is associated with major depression but not with bipolar disorder.
    Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Narozna B; Rajewska-Rager A; Wilkosc M; Zaremba D; Maciukiewicz M; Twarowska-Hauser J
    J Affect Disord; 2014 Aug; 164():33-7. PubMed ID: 24856550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
    Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
    J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
    Lin YF; Huang MC; Liu HC
    J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.
    Rybakowski JK; Czerski P; Dmitrzak-Weglarz M; Kliwicki S; Leszczynska-Rodziewicz A; Permoda-Osip A; Skibinska M; Suwalska A; Szczepankiewicz A; Hauser J
    J Psychopharmacol; 2012 Mar; 26(3):368-73. PubMed ID: 21890592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.